Lv3
300 积分 2023-09-19 加入
Education programmes for people with chronic kidney disease and diabetes
4天前
待确认
Perspectives in weight control in diabetes – Survodutide
19天前
已完结
Polyagonists in Type 2 Diabetes Management
19天前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
19天前
已完结
Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity
19天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
19天前
已完结
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
19天前
已完结
Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials
19天前
已完结
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
19天前
已完结
Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review
22天前
已完结
皖公网安备34019202002308
